NASDAQ:AERI
Delisted
Aerie Pharmaceuticals Stock News
$15.25
+0 (+0%)
At Close: Feb 17, 2023
Aerie Pharmaceuticals Inc (NASDAQ:AERI) Shares Purchased by Geode Capital Management LLC
07:20am, Saturday, 04'th Jul 2020
Geode Capital Management LLC increased its stake in shares of Aerie Pharmaceuticals Inc (NASDAQ:AERI) by 7.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchan
Legal & General Group Plc Has $285,000 Position in Aerie Pharmaceuticals Inc (NASDAQ:AERI)
06:44am, Saturday, 04'th Jul 2020
Legal & General Group Plc lessened its position in Aerie Pharmaceuticals Inc (NASDAQ:AERI) by 8.5% in the 1st quarter, Holdings Channel reports. The firm owned 21,085 shares of the company’s stock a
Victory Capital Management Inc. Has $88,000 Stock Holdings in Aerie Pharmaceuticals Inc (NASDAQ:AERI)
06:06am, Saturday, 04'th Jul 2020
Victory Capital Management Inc. lessened its stake in shares of Aerie Pharmaceuticals Inc (NASDAQ:AERI) by 22.2% during the 1st quarter, according to the company in its most recent Form 13F filing wit
Is Aerie Pharmaceuticals a Buy?
12:11pm, Thursday, 02'nd Jul 2020
Wall Street has given the eye-care specialist the cold shoulder in 2020. Is that an opportunity for individual investors?
Aerie Pharma (AERI) Gets a Buy Rating from Needham - Markets
12:16pm, Friday, 26'th Jun 2020
In a report released today, Serge Belanger from Needham assigned a Buy rating to Aerie Pharma (AERI – Research Report),
The Global Ophthalmology Therapeutics Market will grow by USD 10.42 bn during 2020-2024
Aerie Pharmaceuticals (NASDAQ:AERI) Now Covered by Needham & Company LLC
02:18am, Sunday, 21'st Jun 2020
Analysts at Needham & Company LLC initiated coverage on shares of Aerie Pharmaceuticals (NASDAQ:AERI) in a research report issued on Friday, TipRanks reports. The brokerage set a “buy” rating and
Alliancebernstein L.P. Purchases 78,385 Shares of Aerie Pharmaceuticals Inc (NASDAQ:AERI)
06:00am, Saturday, 20'th Jun 2020
Alliancebernstein L.P. grew its position in shares of Aerie Pharmaceuticals Inc (NASDAQ:AERI) by 11.8% during the 1st quarter, according to the company in its most recent filing with the Securities &
Needham Maintains a Buy Rating on Aerie Pharma (AERI) - Markets
12:55pm, Friday, 19'th Jun 2020
In a report released today, Serge Belanger from Needham maintained a Buy rating on Aerie Pharma (AERI – Research Report),
Aerie Pharmaceuticals Inc (AERI): Hedge Funds Are Nibbling
10:04pm, Monday, 15'th Jun 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Aerie Takes to TikTok to Spread Positivity in Quarantine
01:51pm, Friday, 12'th Jun 2020
The platform's most followed user, Charli D'Amelio, launches #AerieREAL Positivity challenge.
Aerie Pharma (AERI) Received its Third Buy in a Row - Markets
12:43pm, Friday, 12'th Jun 2020
After Mizuho Securities and Oppenheimer gave Aerie Pharma (NASDAQ: AERI) a Buy rating last month, the company received another Buy,
Aerie Pharmaceuticals Appoints Peter J. McDonnell, M.D., to the Company’s Board of Directors
10:30am, Thursday, 11'th Jun 2020
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients wi
Aerie Looks Modestly Undervalued Despite High Cash Burn (NASDAQ:AERI)
01:33pm, Saturday, 06'th Jun 2020
Aerie has 2 marketed products and decent pipeline after a recent acquisition. Aerie unfortunately still has extremely high cash burn for a company of its size.
Aerie (AERI) Up 1.9% Since Last Earnings Report: Can It Continue?
03:31pm, Friday, 05'th Jun 2020
Aerie (AERI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
